Lynparza 50 mg hard capsules * Show product notice

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Summary of Product Characteristics last updated on 6/9/2021 Download PDF

Product Notice

Discontinued Strength Notice

Reminder: Lynparza 50 mg Hard Capsules have been discontinued. It is expected that stock will be depleted by December 2021.